ZO Skin Health, the renowned clinical dermatological skincare brand founded by Dr. Zein Obagi, has recently announced the appointment of Justin Skala as its new CEO. With a background of more than 35 years in leadership positions, Skala brings a wealth of experience in growing high efficacy products through the professional channel. His record includes the expansion of the personal care category during his tenure at Colgate-Palmolive.
Expressing his enthusiasm for joining the ZO Skin Health team, Skala acknowledges his admiration for Dr. Obagi’s visionary approach to redefining skincare. He states, “I’ve long admired Dr. Obagi’s vision for redefining the concept of skincare and could not be more excited to join this incredible team.” His appointment follows the departure of Mark Williams, who will continue to contribute to the company in his role as a member of the Board of Directors.
Todd Hirsch, the Board Chair, recognizes Skala’s remarkable experience in fueling the growth of iconic personal care brands and successfully introducing innovative products to the market. Hirsch emphasizes that Skala’s dedication to providing patients with clinically efficacious regimens will be immensely valuable in driving the continued growth of ZO Skin Health.
Before joining ZO Skin Health, Skala held executive positions at Standard Industries, a global leader in building solutions, solar technology, and chemical products. Prior to that, Skala held various executive leadership roles at Colgate-Palmolive, where he led global strategy and growth across a wide range of product categories, including oral, personal, skin care, home care, and pet nutrition.
